5th Antigen Specific Immune Tolerance Digital Summit
Evvnt Promotion / evvnt
Archiv
26.01.2022 - 27.01.2022Online, USA
Time: 08:00 - 17:30
Kongressthemen Molecular mechanisms underlying tolerance induction remain to be elucidated and some clinical setbacks have highlighted the need to lean into the translational challenges the space is facing.
Speakers: Poul Sorensen Professor, Chief Scientific Officer and Co-Founder Allero Therapeutics, Rupert Sandbrink Chief Executive Officer Cellerys and more.
